XClose

RESEARCH DOMAINS

PERSONALISED MEDICINE

Home bam
Menu

Personalised Medicine News

Refining the genetic causes of schizophrenia

An international study involving UCL has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.

Published: Aug 30, 2016 3:34:22 PM

Heart drug could reduce diabetes related blindness

Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.

Published: Jun 14, 2016 1:02:15 PM

Cancer drugs could target autoimmune diseases

Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.

Published: Jun 10, 2016 4:18:28 PM

New team to develop radiotherapies that target cancer more effectively

Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust.

Published: Apr 22, 2016 9:36:29 AM

Cancer drug could treat blood vessel deformities

A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.

Published: Mar 31, 2016 12:48:52 PM

New drug shows promise against muscle wasting disease

A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.

Published: Mar 24, 2016 9:19:13 AM

Tumours contain the seeds of their own destruction

Scientists at UCL have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system, even when the disease is at its most advanced stages.

Published: Mar 4, 2016 9:35:45 AM

Resistance to key HIV drug ‘concerningly common’

HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL and funded by the Wellcome Trust.

Published: Jan 29, 2016 10:02:47 AM

Early chemotherapy improves survival for men with prostate cancer

Two papers from UCL show that having early chemotherapy improves survival for men with prostate cancer. The papers, published in the Lancet and Lancet Oncology, report the results from the STAMPEDE clinical trial and a meta-analysis.

Published: Dec 22, 2015 9:17:00 AM

Improving treatment for systemic amyloidosis

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.

Published: Jul 16, 2015 11:57:29 AM

UCL to coordinate £16m project to crack difficult disease areas

UCL has successfully coordinated a £16 million bid to work with the Medical Research Council (MRC), GSK and four other universities to improve scientists’ understanding of inflammatory and fibrotic diseases that present a serious burden to patients.

Published: Jul 15, 2015 10:25:45 AM

View all articles